Navigation Links
Peripheral Vascular Devices Market - New Market Research Report Published by Transparency Market Research
Date:5/10/2013

Albany, New York (PRWEB) May 10, 2013

The growth of the peripheral vascular devices market is driven by factors such as rising incidence of peripheral vascular diseases, increasing minimally invasive procedures and the aging population. The Asia-Pacific region offers future growth prospects to the peripheral vascular devices industry owing to vast unmet medical needs and rising disposable income of patients.

Related Report : E-Prescribing Market
http://www.transparencymarketresearch.com/e-prescribing-market.html

Geographically, the North American peripheral vascular devices market held majority of the market share of approximately 41% in 2011 owing to its developed economy. However, due to rise in aging population and increase in number of peripheral and lower limb procedures, the demand for peripheral vascular devices is expected to increase in the coming years.

Related Report : Orthopedics Market
http://www.transparencymarketresearch.com/orthopedics-market.html

Emerging countries such as India, China and other Latin American countries will see a healthy growth in the study period. Economic growth and improvements in healthcare facilities in emerging economies is expected to boost the demand in these regions. However, with a double digit growth rate, the Asia-Pacific region will emerge as the fastest growing market due to the rapidly growing population, growing economies, increasing awareness and rising disposable incomes.

Browse the full report with TOC at http://www.transparencymarketresearch.com/peripheral-vascular-devices-market.html

Peripheral vascular stents represented the largest segment of the total peripheral vascular devices market accounting for more than 25% share in 2011, whereas embolic protection devices represent the fastest growing segment during the forecast period. New market players are coming up with next-generation products which address the issues raised by surgeons regarding earlier products and meet their demands.

Some of the key players in this market include Abbott Vascular, Boston Scientific Corporation, Cordis Corporation, Medtronic Inc. and others. Large players acquire smaller players to expand their current peripheral vascular devices portfolio and also to expand their geographical presence.

Browse all market research reports: http://www.transparencymarketresearch.com/

Read the full story at http://www.prweb.com/releases/2013/5/prweb10716959.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Research leads to better understanding of peripheral neuropathy
2. Boston college biologist awarded NIH grant to probe link between HIV and peripheral neuropathy
3. AxoGen, Inc. Announces Presentation of Avance® Nerve Graft Data at American Society for Peripheral Nerve & American Society for Reconstructive Microsurgery 2013 Meetings
4. AxoGen, Inc. to sponsor Educational Symposium and Panel Discussion at 2013 Annual Meetings of American Association for Hand Surgery, American Society for Peripheral Nerve, and American Society for Reconstructive Microsurgery
5. Lifestyle Affects Outcome of Peripheral Artery Procedure: Study
6. Lifestyle changes linked to better outcomes after peripheral intervention
7. Depression linked with increased risk of peripheral artery disease
8. Mayo Clinic completes first genome-wide analysis of peripheral T-cell lymphomas
9. Obstructive sleep apnea is associated with diabetic peripheral neuropathy
10. Vascular Care Center Now Open at HealthCrave
11. Forthcoming study explores use of intermittent fasting in diabetes as cardiovascular disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... ... March 23, 2017 , ... The ... from the NCQA. The accreditation covers StayWell’s asthma, coronary artery disease, congestive heart ... granted to organizations that have excellent programs for the delivery and improvement of ...
(Date:3/23/2017)... ... March 23, 2017 , ... March 23, 2017 - ... to easily reprint customer invoices, bills, statements and other correspondence when they have ... needed to retrieve and print the documents and batch them for efficient handling. ...
(Date:3/23/2017)... OR (PRWEB) , ... March 23, 2017 , ... Sharon ... Water, Global Climate Change and Your Health on VoiceAmerica, recently talked on her program ... she also used the occasion to remind listeners of an important distinction. World Water ...
(Date:3/23/2017)... ... March 23, 2017 , ... Corra Group is ... competitive pricing. Verisys through its FACIS and other services maintains the ... actions. , “We are delighted to be able to offer these various products ...
(Date:3/23/2017)... ... March 23, 2017 , ... ... New MEDDEV 2.7/1 Rev. 4 Guidance, **An FDAnews Webinar**, April 4, 2017 ... will the new EU MDR language change the way manufacturers approach CERs? ...
Breaking Medicine News(10 mins):
(Date:3/23/2017)... 23, 2017  Cornerstone Pharmaceuticals, Inc., a ... milestone today.  Following successful End-of-Phase I (EOP1) ... and Drug Administration (FDA), the Company has ... path forward to conduct pivotal trials of ... acute myeloid leukemia (AML) and pancreatic cancer. ...
(Date:3/23/2017)... March 23, 2017 Piramal ... Limited, anuncia el nombramiento de Stuart E. ... plataforma de servicios integrados completa para su base ... cargo clave en el crecimiento y ejecución de ... responsable de impulsar todas las actividades de desarrollo ...
(Date:3/23/2017)... Merrimack Pharmaceuticals, Inc. (NASDAQ: MACK ) ... a Phase 1 study of MM-310 in solid tumors. ... novel taxane and targets the EphA2 receptor, a protein ... major tumor types, including prostate, ovarian, bladder, gastric, pancreatic ... study is an important step in evaluating MM-310,s safety ...
Breaking Medicine Technology: